MALVERN, Pa., Jan. 2, 2018 /PRNewswire/ -- Realm Therapeutics
plc (AIM: RLM), a clinical stage biopharmaceutical company focused
on leveraging its proprietary immunomodulatory technology, is
pleased to announce that Alex
Martin, CEO, will be presenting at the 5th Annual
Dermatology Summit, an Advancing Innovation in Dermatology
conference, on Sunday, January 7,
2018 at 2:15 p.m. PT at the
Palace Hotel in San Francisco,
CA.
An updated copy of Realm's corporate presentation is available
on the Company's website at www.realmtx.com.
About Realm Therapeutics
Realm Therapeutics is a clinical-stage biopharmaceutical company
focused on developing novel immunomodulatory therapies to protect
and improve the lives of adults and children. The Company has
initiated drug development programs, based on its proprietary
hypochlorous acid technology at high concentrations. The Company
believes its formulations have novel immunomodulatory activity with
potential application for the treatment of diseases in a number of
therapeutic areas, including Dermatology and
Ophthalmology.
Forward Looking Statements
Certain statements made in this announcement are
forward-looking statements. These forward-looking statements are
not historical facts but rather are based on the Company's current
expectations, estimates, and projections about its industry; its
beliefs; and assumptions. Words such as 'anticipates,'
'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,'
and similar expressions are intended to identify forward-looking
statements. These statements are not guarantees of future
performance and are subject to known and unknown risks,
uncertainties, and other factors, some of which are beyond the
Company's control, are difficult to predict, and could cause actual
results to differ materially from those expressed or forecasted in
the forward-looking statements. The Company cautions shareholders
and prospective shareholders not to place undue reliance on these
forward-looking statements, which reflect the view of the Company
only as of the date of this announcement. The forward-looking
statements made in this announcement relate only to events as of
the date on which the statements are made. The Company will not
undertake any obligation to release publicly any revisions or
updates to these forward-looking statements to reflect events,
circumstances, or unanticipated events occurring after the date of
this announcement except as required by law or by any appropriate
regulatory authority.
View original
content:http://www.prnewswire.com/news-releases/realm-therapeutics-to-present-at-the-5th-annual-dermatology-summit-300576274.html
SOURCE Realm Therapeutics